RevBio Initiates its Pivotal Clinical Trial in Europe for its Dental Implant Stabilization Product
The Company Received Approval in Multiple European Countries to Initiate this Key Study Necessary for Commercial Product Approval LOWELL, Mass.–(BUSINESS WIRE)–RevBio, Inc., announced that it has received regulatory and ethics committee approvals in multiple European countries to conduct its pivotal... Read More →
Maria Artunduaga, Founder and CEO of Samay selected for Inc. Magazine’s 2025 Female Founders list
For developing a non-invasive lung function monitoring device to support people with respiratory conditions, conducting extensive clinical trials, and securing the largest funding round for a Latina-led medtech company in the U.S. Read More
Spineart and eCential Robotics announce FDA clearance of PERLA® App for use with Op.nTM robotic navigation platform
Spineart and eCential Robotics announce FDA clearance of PERLA® App for use with Op.nTM robotic navigation platform Dallas, Texas and Franklin, Tennessee, March 13, 2025 — Spineart, a fast-growing company in spine surgery innovation, and eCential Robotics, an expert company... Read More →
Implantable Bioelectronic Device to Reverse Degenerative Disc Disease featuring Discure Technologies
The Discure System from Discure Technologies Ltd. is a bioelectronic treatment for mid-stage degenerative disc disease (DDD), providing a minimally invasive, outpatient procedure that reduces pain and restores spine function. The Discure System from Discure Technologies Ltd. is changing the... Read More →
MicroTransponder Secures $65 Million to Enhance Vivistim Adoption for Chronic Stroke Recovery
AUSTIN, Texas, March 12, 2025 /PRNewswire/ — Announcing a $65 million Series F financing round, MicroTransponder®, Inc., one of the fastest-growing stroke companies, is transforming the stroke continuum of care with its FDA-approved Vivistim® Paired VNS™ System. The round was... Read More →
Growing Market Applications, Centerline Biomedical Granted FDA 510(k) Clearance for IOPS® with New, Expanded Indication for Use
CLEVELAND–(BUSINESS WIRE)–Centerline Biomedical, Inc. (“Centerline”), an innovative leader in cardiovascular navigation and visualization systems, announced that the company has received US Food and Drug Administration (FDA) 510(k) clearance of expanded indications for its Intra-Operative Positioning System (IOPS). This news is... Read More →
Translation of Laparoscopic Surgical Innovation: Discovering and Deciphering Practices and Policy Impacts featuring ClearCam
Christopher R. Idelson, ClearCam; Maansi Srinivasan, ClearCam; Austin Fagerberg, McGovern Medical School, The University of Texas, ClearCam; John M. Uecker, Dell Medical School, The University of Texas at Austin and ClearCam; Douglas G. Stoakley, ClearCam; Marian Yvette Williams-Brown, Dell Medical... Read More →
May Health Appoints Seasoned Medtech Executive, Colby Holtshouse, as President and CEO
Leadership transition comes as Company focuses on clinical evaluation of its novel Ovarian Rebalancing™ technology, a one-time transvaginal ablation procedure designed to restore ovulation in women with PCOS, a leading cause of infertility PARIS, March 10, 2025 /PRNewswire/ — May... Read More →
Lungpacer wins FDA IDE for AeroNova system
Lungpacer Medical announced today that it received FDA investigational device exemption (IDE) to begin a trial for its AeroNova system. The STARI (stimulation to activate respiration) trial evaluates the feasibility of the investigational AeroNova system. It looks at the system... Read More →
CLEW Announces the Launch of its Sepsis Virtual Unit to Enhance SEP-1 Compliance and Improve Patient Outcomes
BOSTON, March 10, 2025 /PRNewswire/ — CLEW, a leading provider of AI-driven clinical surveillance solutions, today announced the launch of its Sepsis Virtual Unit (SVU), designed to help healthcare organizations improve sepsis detection, enhance SEP-1 compliance, and drive better patient... Read More →